(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery. In a report in the Proceedings of the National Academy of Sciences, ...
NRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical study comparing adjuvant chemotherapy with or without chemoradiation for patients with ...
Jun 4, 2024
0
1
Stomach cancer is caused by an uncontrolled growth of cells that starts in the stomach. Most stomach cancers are found when the disease has spread beyond the stomach, when a cure is less likely.
May 30, 2024
0
1
A UCLA-led study suggests that women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
May 10, 2024
0
33
A new perspective paper explores the current state and future directions of precision medicine in colorectal cancer (CRC). It outlines advancements in molecular testing and their implications for targeted and immunological ...
May 2, 2024
0
0
For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal therapy alone, according ...
Apr 17, 2024
0
2
Researchers at Peter Mac have found a new way to treat a form of leukemia that stops the disease in its tracks to prolong remission.
Apr 15, 2024
0
1
Recent progress in research related to cancer treatment has made it possible for children with cancer to survive into adulthood. However, the long-term physiological consequences of chemotherapy are understudied.
Apr 4, 2024
0
0
People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.
Feb 26, 2024
0
0
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding and managing this disease.
Feb 16, 2024
0
0
